Researcher biography

Andrew Kneynsberg earned his doctorate in Neuroscience from Michigan State University, United States of America in 2018. He completed his doctoral work in the laboratory of Dr. Nicholas Kanaan on the role of the axon initial segment and tau modifications in axosomatic tau distribution. Andrew relocated to the Queensland Brain Institute as a Research Fellow in the Clem Jones Centre for Alzheimer’s Disease Research under the guidance of Dr. Jürgen Götz.

Trained as a molecular biologist, Andrew investigates the functions and properties of the protein Tau. Alzheimer’s disease and other neurodegenerative diseases (termed tauopathies) are characterized by the accumulation of the tau protein, yet the role of tau is poorly understood. Focusing on the features of tau in healthy cells, he uses rodent neurons to better characterize the localization and functions of tau. Through better understanding of healthy neurons, this research will hopefully lead to new avenues for therapeutics.